BTS #34 Sher Ali Butt of CB Therapeutics on Biosynthesizing Cannabinoids and Psychedelics



In this behind-the-scenes interview we sit down with Sher Ali Butt, the co-founder of CB Therapeutics, a company focused on biosynthesizing cannabinoids and psychedelics using fermentation with fungi. We talk about the science behind biosynthetic technology, why they have chosen to focus on psychedelics and cannabinoids, how biosynthesis compares to chemical synthesis techniques for producing compounds, why isolated compounds and complex herbal mixtures can both have a place in healthcare, and much more!

Learn more about CB Therapeutics at www.cbthera.com


One thought on “BTS #34 Sher Ali Butt of CB Therapeutics on Biosynthesizing Cannabinoids and Psychedelics

  1. Very informative, interesting and suggesting treatment of common medical problems. It was highly needed and CB Therapeutics has provided solution to many problems.

Leave a Reply

*